PROTAK SCIENTIFIC LIMITED
No Analysis Available
Get instant AI-powered insights about this company's financial health, risks, and trends.
Order Analysis - £10- Legal registered address
- Luminox House Holmethorpe Avenue Redhill England RH1 2NL Copied!
Latest financial results as of 22 September 2025- Cash in bank
- £621.82k
- Current assets
- £961.12k
- Fixed assets
- £46.00k
- Current creditors
- £679.88k
- Shareholders funds
- £1.90m
View full financial accounts- Cash in bank
- £621.82k
- Current assets
- £961.12k
- Fixed assets
- £46.00k
- Current creditors
- £679.88k
- Shareholders funds
- £1.90m
- Company number
- 09318477 Copied!
Accounts
Latest annual accounts were to 31 December 2023
Next annual accounts are due by 30 September 2025
Company financial year end is on 31 December 2025
Confirmation statement
Latest confirmation statement statement dated 18 March 2025
Next statement due by 1 April 2026
Nature of business (SIC)
21100 - Manufacture of basic pharmaceutical products
Latest company documents
Date | Description |
---|---|
07/04/257 April 2025 | Confirmation statement made on 2025-03-18 with no updates |
30/09/2430 September 2024 | Total exemption full accounts made up to 2023-12-31 |
18/03/2418 March 2024 | Confirmation statement made on 2024-03-18 with updates |
03/03/243 March 2024 | Change of details for Mr Andrew Charles Parker as a person with significant control on 2024-01-16 |
13/02/2413 February 2024 | Confirmation statement made on 2023-11-19 with updates |
More Company Information
- Company overview
- All company documents and filing history
- People connected with this company
- Financial details of PROTAK SCIENTIFIC LIMITED
- Who controls this company?
- Charges and Mortgages registered against company
- The Company's website
- Location, contact details and map
- Related companies and people
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company